These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3192922)

  • 1. Effect of propranolol on metabolic activity of the liver in patients with alcoholic cirrhosis.
    Vinel JP; Caucanas JP; Calès P; Suduca JM; Voigt JJ; Pascal JP
    J Hepatol; 1988 Oct; 7(2):186-92. PubMed ID: 3192922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verapamil has no effect on porto-hepatic pressure gradient, hepatic blood flow and elimination function of the liver in patients with liver cirrhosis.
    Vinel JP; Caucanas JP; Combis JM; Cales P; Voigt JJ; Pascal JP
    J Hepatol; 1989 May; 8(3):302-7. PubMed ID: 2732444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral propranolol on splanchnic oxygen uptake and haemodynamics in patients with cirrhosis.
    Bendtsen F; Henriksen JH; Becker U; Sørensen TI
    J Hepatol; 1987 Oct; 5(2):137-43. PubMed ID: 3693857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of verapamil and isosorbide dinitrate on the hepatic clearance of indocyanine green in cirrhosis.
    Merkel C; Bolognesi M; Angeli P; Finucci GF; Amodio P; Bellon S; Gatta A
    Br J Clin Pharmacol; 1990 Aug; 30(2):221-7. PubMed ID: 2206784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic effects of molsidomine and propranolol in patients with cirrhosis.
    Combis JM; Vinel JP; Badia P; Barange K; Payen JL; Combis F; Desmorat H; Pascal JP
    Br J Clin Pharmacol; 1996 May; 41(5):409-13. PubMed ID: 8735682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis.
    Pind ML; Bendtsen F; Kallemose T; Møller S
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):948-54. PubMed ID: 27172450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
    García-Pagán JC; Escorsell A; Feu F; Bandi JC; Moitinho E; Casado M; Bosch J; Rodés J
    J Hepatol; 1996 Apr; 24(4):430-5. PubMed ID: 8738729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
    García-Pagán JC; Feu F; Bosch J; Rodés J
    Ann Intern Med; 1991 May; 114(10):869-73. PubMed ID: 2014947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of clonidine in patients with alcoholic cirrhosis. Hemodynamic and liver function effects.
    Albillos A; Bañares R; Barrios C; Clemente G; Rossi I; Escartin P; Bosch J
    Gastroenterology; 1992 Jan; 102(1):248-54. PubMed ID: 1727758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol does not further decrease the clearance of antipyrine in patients with alcoholic cirrhosis.
    Larrey D; Lebrec D; Bercoff E; Pessayre D
    Clin Sci (Lond); 1983 Aug; 65(2):203-5. PubMed ID: 6602683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score.
    Merkel C; Gatta A; Zoli M; Bolognesi M; Angeli P; Iervese T; Marchesini G; Ruol A
    Dig Dis Sci; 1991 Sep; 36(9):1197-203. PubMed ID: 1893804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of liver blood flow and function on hepatic indocyanine green clearance measured directly in a cirrhotic animal model.
    Jiao LR; El-Desoky AA; Seifalian AM; Habib N; Davidson BR
    Br J Surg; 2000 May; 87(5):568-74. PubMed ID: 10792311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol and haemodynamic response in cirrhosis.
    Bendtsen F; Henriksen JH; Sørensen TI
    J Hepatol; 1991 Sep; 13(2):144-8. PubMed ID: 1744417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperendothelinemia and ICG clearance in alcoholic and nonalcoholic cirrhosis.
    Maruyama S; Hirayama C; Yamamoto S; Koda M; Udagawa A; Kadowaki Y; Inoue M; Sagayama A; Umeki K
    Dig Dis Sci; 2002 Apr; 47(4):773-7. PubMed ID: 11991608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodological limitations of the use of intrinsic hepatic clearance of ICG as a measure of liver cell function.
    Keiding S; Skak C
    Eur J Clin Invest; 1988 Oct; 18(5):507-11. PubMed ID: 3147903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic parenchymal cell volume and the indocyanine green tolerance test.
    Hashimoto M; Watanabe G
    J Surg Res; 2000 Aug; 92(2):222-7. PubMed ID: 10896825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic clearances of antipyrine, indocyanine green, and galactose in normal subjects and in patients with chronic liver diseases.
    Kawasaki S; Sugiyama Y; Iga T; Hanano M; Beppu T; Sugiura M; Sanjo K; Idezuki Y
    Clin Pharmacol Ther; 1988 Aug; 44(2):217-24. PubMed ID: 3396264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of moderate haemodilution with Fluosol-DA or normal saline on indocyanine green and (+)-propranolol kinetics.
    Shrewsbury RP; Lewis LM; Oliver SR; Womble CL
    J Pharm Pharmacol; 1987 Aug; 39(8):592-8. PubMed ID: 2888848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism for the abnormal liver scan in acute alcoholic liver injury.
    Hoefs JC; Green G; Reynolds TB; Sakimura I
    Am J Gastroenterol; 1984 Dec; 79(12):950-8. PubMed ID: 6507421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatic extraction of taurocholate and indocyanine green in patients with liver disease (author's transl)].
    Paumgartner G; Vasella DL; Herz R; Reichen J; Preisig R
    Z Gastroenterol; 1979 Nov; 17(11):753-61. PubMed ID: 524951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.